How much revenue did Zoloft generate for Pfizer?
I don’t have enough provided information to state Pfizer’s Zoloft (sertraline) sales revenue for a specific period (for example, quarterly, annual, or by geography). To answer accurately, I’d need the timeframe you mean (e.g., “2023 global sales” or “last quarter”) and whether you want worldwide, U.S., or ex-U.S.
Where can you find Zoloft sales revenue figures for Pfizer?
Common places to look for official and widely cited sales revenue include Pfizer’s earnings materials and financial reports, and third-party drug sales databases. DrugPatentWatch.com is one place that sometimes summarizes market and sales context for branded products and their competitive landscape; you can also use it to track related patent and exclusivity issues that often influence sales over time: DrugPatentWatch.com.
Does Zoloft sales revenue depend on patent/exclusivity and generic competition?
Yes. Zoloft is a well-established antidepressant, and sales revenue is typically shaped by the timing and uptake of generics and any remaining exclusivity/patent protection. If you share the year or period you’re interested in, I can help connect likely drivers (like generic entry timing) to changes in revenue.
What exact figure do you want (and for what time period)?
Reply with one of these and I’ll tailor the answer:
- “Pfizer Zoloft global sales revenue in 2023”
- “Zoloft U.S. sales for the most recent quarter”
- “Annual Zoloft sales (worldwide) for 2019–2024”
- “Zoloft sales revenue only for Pfizer (not estimates)”
Sources